Elutia (ELUT) Capital Expenditures Growth (1y) (2020 - 2026)
Elutia (ELUT) Capital Expenditures Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.22 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 128.20 Bn | 125.32 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 107.69 Bn | 98.47 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 68.05 Bn | 66.59 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 47.52 Bn | 43.85 Bn | 1.29 Bn | 15.89% |
| 6 | GE HealthCare Technologies | 28.46 Bn | 26.17 Bn | 1.98 Bn | 106.98% |
| 7 | Dexcom | 28.25 Bn | 27.13 Bn | 750.30 Mn | -11.95% |
| 8 | Smith & Nephew | 26.73 Bn | 26.15 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | -47.73% |
| 10 | Elutia | 39.18 Mn | 10.69 Mn | 1.80 Mn | 65.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.11% |
| Dec 31, 2025 | 808.51% |
| Sep 30, 2025 | 15.17% |
| Jun 30, 2025 | 5,800.00% |
| Mar 31, 2025 | 1,753.33% |
| Dec 31, 2024 | 452.94% |
| Sep 30, 2024 | 782.26% |
| Jun 30, 2024 | -102.35% |
| Mar 31, 2024 | -91.76% |
| Dec 31, 2023 | -87.31% |
| Sep 30, 2023 | -47.01% |
| Jun 30, 2023 | -66.67% |
| Mar 31, 2023 | 435.29% |
| Dec 31, 2022 | 436.00% |
| Sep 30, 2022 | 20.62% |
| Jun 30, 2022 | 119.83% |
| Mar 31, 2022 | -74.05% |
| Dec 31, 2021 | -78.26% |
| Sep 30, 2021 | -77.75% |
| Jun 30, 2021 | 329.63% |